Tumors of Lynch syndrome (LS) patients display high levels of microsatellite instability (MSI), 27 which results from complete loss of DNA mismatch repair (MMR), in line with Knudson's two-hit 28 hypothesis. Why some organs, in particular those of the gastrointestinal (GI) tract, are especially 29 prone to tumorigenesis in LS remains unknown. We hypothesized that MMR is haploinsufficient in 30 certain tissues, compromising microsatellite stability in a tissue-specific manner before 31 tumorigenesis. Using mouse genetics, we tested how levels of MLH1, a central MMR protein, affect 32 microsatellite stability in vivo and whether elevated MSI is detectable prior to loss of MMR function 33 and to neoplastic growth. We assayed MSI by sensitive single-molecule PCR in normal jejunum and 34 spleen of 4-and 12-month old Mlh1 +/+ , Mlh1 +/and Mlh1 -/mice, accompanied by measurements of 35 Mlh1 mRNA and MLH1 protein expression levels.
Introduction

II.
In order for an allele to be considered as mutant, both the highest peak and the stutter peaks 139 should shift as a single unit. Shift of the highest peak alone was not scored as a mutant.
140
III.
If a wildtype and (apparently) mutant allele co-occurred in a single PCR, the reaction was 141 scored as wildtype. Non-wildtype peaks were presumed to result from replication slippage 142 during the early rounds of PCR, and thus considered artifacts. in jejunum and spleen of 4-and 12-month-old Mlh1 +/mice ( Fig. 1A) on three microsatellite loci 213 ( Fig. 1B) D14Mt15 was stable ( Fig. 2A, Supplementary fig. 1A and Supplementary fig. 1B ). Deletions at 218 the mononucleotide repeats in Mlh1 +/jejuna were predominantly single repeat unit, i.e. 1 bp, shifts 219 ( Fig. 2A) , and the average deletion% was 6% and 7% at 4 and 12 months, respectively ( Fig. 2B) .
220
Compared to Mlh1 +/+ jejuna, the deletion% in Mlh1 +/jejuna were 3.2-and 3.5-fold higher, and 221 compared to Mlh1 -/jejuna 5.2-and 6.4-fold lower at 4 and 12 months, respectively. Unlike Mlh1 +/-222 jejuna, Mlh1 +/spleens were microsatellite stable at both time points ( Fig. 2A and Fig. 2B ).
223
In contrast to Mlh1 +/tissues, in Mlh1 -/tissues, deletion mutant alleles had bigger size shifts and 224 were more frequent at all three microsatellites at both time points ( Fig. 2A, Supplementary fig. 1A ).
225
Mlh1 -/jejuna showed bigger size shifts and a higher deletion% than Mlh1 -/spleens; both deletion 226 size shifts and deletion% were further increased in Mlh1 -/intestinal tumor ( Fig. 2A, Supplementary   227 fig. 1A). In Mlh1 -/jejuna, the average deletion% at mononucleotide repeats were 32% and 46%, and 228 in Mlh1 -/spleen, 21% and 32% at the 4-and 12-month time points, respectively ( Fig. 2B) . For 229 comparison, the Mlh1 -/intestinal tumor showed 52% deletion ( Fig. 2B) . D14Mit15 displayed 9% 230 and 22% deletions in Mlh1 -/jejuna, 3% and 6% in Mlh1 -/spleen at the 4-and 12-month time points, 231 respectively, and 24% in the Mlh1 -/intestinal tumor. Mlh1 +/+ tissues showed 2% deletions at 232 mononucleotide repeats, and no detectable MSI at D14Mit15 at either time point ( Fig. 2B) . 233 Unlike deletions, insertions at all three microsatellites were not influenced by Mlh1 gene dosage:
234
Mlh1 +/+ , Mlh1 +/-, Mlh1 -/mice showed minimal or no difference in insertion% in jejunum and spleen, 235 with the exception of A33 at the 12-month time point ( Fig. 2, Supplementary fig. 1A , 236 Supplementary fig. 1B and Supplementary fig. 2) . At 12 months, A33 showed a decreasing trend 237 in insertion% with decreased Mlh1 gene dosage in both tissues (Supplementary fig. 2 ). Irrespective 238 of genotype, tissue-of-origin or age, insertions were almost exclusively single repeat unit in size (1 239 bp and 2 bp for mono-and dinucleotide repeats, respectively) ( Fig. 2A and Supplementary fig. 1A ).
240
One 4-month old Mlh1 +/mouse showed substantially elevated deletion% in jejunum (25% and 4% 241 at mononucleotide markers and at D14Mit15, respectively; indicated by an arrow in Fig. 2B) shifts (Supplementary fig. 3) . Moreover, inter-individual variation in mononucleotide deletion% 246 was evident in Mlh1 +/jejuna in both age groups (Fig. 2B) .
247
Mlh1 +/mice show sporadic decrease in Mlh1 expression levels in jejunum 248
To assess whether the inter-individual variation in deletion% in Mlh1 +/jejuna can be explained by 249
Mlh1 expression levels, we quantified Mlh1 mRNA and MLH1 protein levels; Mlh1 +/spleens, which 250 were microsatellite-stable ( Fig. 2B) , were used as control tissue. To further examine tissue-specific 251 differences in Mlh1 expression, we analyzed Mlh1 mRNA expression in brain, kidney and liver. We 
) and 17% (range: 1%-29%), respectively (Fig. 3A) . These age-specific decreases in Mlh1 263 mRNA and MLH1 protein were not statistically significant, however.
264
To investigate whether younger mice show similar aberration in Mlh1 expression levels, we analyzed 265 Mlh1 mRNA expression levels also at 1-month time point. As the older cohorts, 1-month Mlh1 +/-266 jejuna also showed less-than-expected-and variable Mlh1 mRNA expression levels (average: 30%, 267 range: 21%-37%). 1-month old Mlh1 +/mice showed a significant decrease in Mlh1 mRNA levels in 268 jejunum (p=0.0283) when compared to 12-month old Mlh1 +/mice (Supplementary fig. 4 ).
269
Irrespective of age, we observed approximately expected 50% Mlh1 mRNA and MLH1 protein levels 270 in all the Mlh1 +/spleens (Fig. 3A, Fig. 3C and Supplementary fig. 4) . Jejunum of the outlier 271 Mlh1 +/mouse showed only 8% Mlh1 mRNA expression ( Fig. 3A) and no detectable MLH1 protein 272 (Fig. 3C) , while its spleen had the expected levels of Mlh1 mRNA and MLH1 protein ( Fig. 3A and 273 Fig. 3C ). 274 We also assayed Mlh1 mRNA expression in brain, kidney and liver of two 4-month old Mlh1 +/mice 275 that expressed below age-average Mlh1 mRNA levels in their jejunum; Mlh1 mRNA expression in 276 these tissues were as expected (60%, 56% and 56%, respectively) (Supplementary fig. 5 ).
277
Substantial inter-individual variation in MLH1 protein expression in Mlh1 +/jejuna was also 278 detectable by IHC. Based on staining intensity, jejuna of half the Mlh1 +/mice (n=6) were scored as
279
MLH1-positive and the other half was scored as low MLH1-positive by IHC profiler (Fig. 3D) . Supplementary fig. 6 ).
287
Sporadic depletion of MLH1 in Mlh1 +/jejuna is primarily due to Mlh1 promoter methylation 288 The variable MLH1 protein levels in jejunum of Mlh1 +/mice ranging from approximately expected 289 50% of Mlh1 +/+ to no expression ( Fig. 3C) prompted us to investigate the cause of this sporadic 290 MLH1 depletion. To distinguish between a genetic (loss of heterozygosity) and epigenetic mechanism 291 (methylation of the Mlh1 promoter), we performed LOH and MSP assays. Mlh1 promoter methylation 292 in jejunum was common (detected in 7/12 and 9/11 Mlh1 +/mice at 4 and 12 months, respectively; 293 see Table 1 ). Irrespective of age, all Mlh1 +/mice with extremely low (less than 3%) MLH1 protein 294 expression in jejunum (4/8 and 2/6 Mlh1 +/mice at 4 and 12 months, respectively) displayed Mlh1 295 promoter methylation (Fig. 4) . Additionally, three of the four 12-month old Mlh1 +/mice with higher level of MLH1 expression (range: 18%-29%) showed Mlh1 promoter methylation, while none (out 297 of four) of the 4-month old Mlh1 +/mice with higher MLH1 levels (range: 18%-52%) had Mlh1 298 promoter methylation (Fig. 4) . 299 LOH was only observed in the outlier 4-month old Mlh1 +/mouse which also had Mlh1 promoter 300 methylation (Fig. 4) . All other Mlh1 +/mice assayed (n=22) test: p-value = 1.9x10 -6 and 2.9x10 -4 for 4 and 12 months, respectively) ( Fig. 5A) . Further, based on 308 this correlation, at both the time points, Mlh1 +/mice could be divided into two sub-groups, 309 henceforth termed as sub-grp.1 and sub-grp.2, and defined by comparatively higher MLH1 protein 310 levels and lower deletion% at mononucleotide repeats, versus low MLH1 protein levels and higher 311 deletion% in jejunum, respectively.
312
At the 4-month time point, sub-grp.1 showed close-to-expected (approximately 50% of wildtype) 313 average MLH1 protein levels (average 41%, range: 18%-54%) and 5% deletions. Sub-grp.2 had very 314 low MLH1 protein levels (average: 2%, range: 0%-3%) and showed 10% deletions (Fig. 5B) . 315 Compared to Mlh1 +/+ jejuna, sub-grp.1 and sub-grp.2 showed 2.5-and 5-fold increase in deletion%, 316 respectively. At the 12-month time point, sub-grp.1 showed lower-than-expected average MLH1 317 expression (average 24%, range: 18%-27%) and 7% deletions. Sub-grp.2, similarly as observed at 4 318 months, showed very low MLH1 protein levels (average: 1%, and range: 0%-2%) and increase in 319 10% deletions (Fig. 5B) . Compared to Mlh1 +/+ jejuna, sub-grp.1 and sub-grp.2 showed 3-and 5-fold 320 increase in deletion%, respectively.
321
Irrespective of age, all Mlh1 +/spleens showed the expected approximately 50% MLH1 protein level, 322 and no increase in deletion% compared to Mlh1 +/+ spleens (Supplementary fig. 9 ). The Mlh1 +/-323 outlier mouse (indicated by arrow in Fig. 5A and Fig. 5B) Compared to 4-month-old Mlh1 +/mice, no further substantial increase in deletions was observed in 335 jejunum of 12-month-old Mlh1 +/mice; in Mlh1 -/mice this increase was seen prominently 336 (Supplementary fig. 10 ). This observation i.e. no strong correlation between MSI and age in MMR 337 heterozygous condition is in line with previous studies [14, 15] . This can be explained by age-338 independent sporadic MSI increase in MMR heterozygous condition. In our study, 42% of 4-month 339 old Mlh1 +/mice already showed deletion frequency comparable to 12-month old Mlh1 +/mice. As 340 with MSI levels, no substantial decrease in Mlh1 mRNA and MLH1 protein levels was observed in 341 jejunum between the two age groups. Additionally, 1-month old Mlh1 +/mice also showed a jejunum-342 specific inter-individual variation in Mlh1 mRNA levels, and showed lower than expected Mlh1 343 mRNA levels (Supplementary fig. 4 ), suggesting that the cellular changes (including MSI) may 344 occur even earlier. Supplementary fig. 11 Supplementary fig. 11 ), succumbed to MMR-associated tumors.
371
Ours is the first systematic study that establishes the relationship between MLH1 that sufficiently sensitive assays are used [46, 47] . We propose that tissue-specific decrease in protein 
